Rani Therapeutics Holdings (RANI) Property, Plant & Equipment (Net) (2020 - 2026)

Rani Therapeutics Holdings (RANI) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	66,801.52 Bn	66,801.23 Bn	-	642,333.36
2	Nanobiotix	1,908.00 Bn	1,907.94 Bn	-	5.32 Mn
3	Akari Therapeutics	959.56 Bn	959.56 Bn	-	-
4	BeOne Medicines	472.27 Bn	467.47 Bn	1.35 Bn	1.64 Bn
5	Vertex Pharmaceuticals	122.18 Bn	114.93 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	70.08 Bn	61.32 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	62.34 Bn	62.34 Bn	-	-
8	Argenx Se	55.86 Bn	50.68 Bn	1.41 Bn	1.96 Bn
9	Alnylam Pharmaceuticals	37.50 Bn	34.49 Bn	959.66 Mn	518.26 Mn
10	Rani Therapeutics Holdings	146.12 Mn	146.12 Mn	-	601,000.00

Download Data